Clinical Reviews

Interface Clinical Services deliver clinical reviews, predominantly in a primary care setting, throughout the UK.

In 2016 alone, we delivered 3,822 clinical reviews in GP practices, often delivering reviews in more than one therapy area, depending on the individual requirements of the authorising clinician and the needs of the patient population.

Clinical Review Services

Clinical Reviews

The capacity of our nationwide clinical team, means we’re conducting clinical review services or clinical audits on a daily basis, working with practices to review their use of medicines, optimise patient care, and investigate disease prevalence in pre-determined therapy areas.

All clinical review services have been expertly created by our service design team, and provides on-site support for clinicians, practice staff, and when requested, directly to patients. Interface deliver clinical reviews in a range of therapy areas, including stroke prevention in atrial fibrillation (AF), osteoporosis, diabetes, asthma and chronic obstructive pulmonary disease (COPD), to name just a few. And we’re continually working with practices to create new reviews and services to meet the needs of the locality.

As well as being designed to ensure effective care for patients, the Interface clinical review services are created to consider the Quality Outcomes Framework (QOF) and look to increase practice prevalence where applicable, complementing our QOF Enhancement Service.

Whilst Interface work with practices at a local level to deliver clinical reviews, we also act as an independent partner with CCGS, health boards, GP federations and industry to offer sponsored or joint working opportunities where available, creating cost and clinical efficiencies for practices and clinicians.

Case Study

The Management of Stroke risk in Atrial Fibrillation

Interface partnered with a practice to assist with the management of stroke risk in atrial fibrillation (AF) patients in order to reduce morbidity and mortality as a result of stroke.

A clinical review was carried out in accordance with individual patients’ stroke risk profiles, current local and national guidelines, and the practice’s preferred antithrombotic intervention strategy.

Service Outcomes

  • 25% of patients were receiving sub-optimal therapeutic management prior to the review.
  • 46 patients were allocated stroke risk scores calculated using CHADS2 AND CHADS2-VASc risk assessment tools in line with QOF requirements.
  • AF patients had their antithrombotic therapy optimised in line with clinical guidelines, and received therapy compliance information and lifestyle advice.

Moving forward, the practice has a comprehensive understanding of - and strategy for - stroke risk stratification and the therapeutic management of stroke risk in patients with AF.

Fill in the form below to send Interface Clinical Services a message, and we will get back to you as soon as possible..


I would like to receive occasional updates about Interface Clinical Services.